KLBAY yields 4.61% · JNJ yields 2.13%● Live data
📍 KLBAY pulled ahead of the other in Year 1
Combined, KLBAY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KLBAY + JNJ for your $10,000?
Klabin S.A., together with its subsidiaries, operates in the paper and pulp industry in Brazil and internationally. It operates through Forestry, Paper, Conversion, and Pulp segments. The Forestry segment engages in the planting and forestry operations of pine and eucalyptus; and sale of wood logs. The Paper segment produces and sells reels of cardboard, kraftliner, and recycled paper. The Conversion segment is involved in the production and sale of corrugated boxes and sheets, and industrial bags. The Pulp segment produces and sells short, long, and fluffed pulp. The company also engages in the reforestation business; manufacture of phytotherapic products; and hotel business. In addition, it provides port, packaging customization, and finance services, as well as invests in other companies. Klabin S.A. was founded in 1899 and is headquartered in São Paulo, Brazil.
Full KLBAY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.